Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range
Abbott Laboratories reported a first-quarter profit of $1.23 billion Wednesday.
The company, based in Abbott Park, Illinois, posted net income of 70 cents per share. Earnings, adjusted for one-time gains and costs, were 98 cents per share.
The results surpassed Wall Street expectations by 2 cents, according to Zacks Investment Research.
The maker of infant formula, medical devices and drugs posted revenue of $9.96 billion in the period, also beating analyst forecasts of $9.85 billion.
Abbott raised the low end of its full-year earnings forecast by five cents. It now expects earnings in the range of $4.55 to $4.70 per share.
Abbott shares, up 10% this year, fell more than 3% Wednesday.
_____
Elements of this story were generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABT at https://www.zacks.com/ap/ABT
Get U-T Business in your inbox on Mondays
Get ready for your week with the week’s top business stories from San Diego and California, in your inbox Monday mornings.
You may occasionally receive promotional content from the San Diego Union-Tribune.